Digital health tools like telemedicine, AI algorithms, and connectivity are playing an increasingly important role in helping prevent and manage disease.
Companies aim to integrate Abbott's FreeStyle Libre glucose sensing with Tandem's insulin delivery products to expand choices for people with diabetes.
New product will be the market’s first and only to enable optimization of all diabetes medications, insulin and non-insulin alike, according to the company.
FDA is aware patients may choose to create these systems or purchase unauthorized or unapproved components or systems because of personal preference or cost.
t:Slim X2 is the first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices.